Global Raynauds Disease Market Overview
Raynaud's phenomenon is an uncommon condition that causes increased blood vessel dilation in the fingers and toes. Raynaud's phenomenon is a condition in which blood vessels narrow due to cold or stress, resulting in primary or secondary Raynaud's phenomenon. The human body is adaptable to its surroundings. In a chilly climate, the body conserves heat by delaying the blood supply to the skin, causing blood vessels to constrict. In the presence of Raynaud's phenomenon, the body's reaction to stress or cold is stronger than usual, which can lead to an attack with blood vessel constriction and tightening. During an attack, the colour of fingers and toes changes from white to blue to red, combined with a chilly and numb sensation. With the end of the episode, blood flow returns to normal, causing throbbing and tingling in the fingers and toes. Raynaud's disease is a gender-biased condition, with women experiencing it at a higher rate.
Global Raynauds Disease Market Dynamics
Increase in R&D by various research and academic institutions
The increase in R&D by various research and academic institutions, as well as biopharmaceutical businesses, points to the development of novel treatment techniques, which will contribute to the expansion of the global Raynaud's phenomenon management market. Raynaud's phenomenon is affected by gender, country, and workplace, all of which have an impact on the regional market. The market has also risen as a result of public awareness campaigns established by the healthcare industry and the government. Lack of professional knowledge, illiteracy, and lack of understanding of the syndrome are some of the reasons limiting the global growth of the Raynaud's phenomenon management market.
Global Raynauds Disease Market Segmentation
The Global Raynauds Disease Market is segmented based on Drug type, Distribution Channel and region.
On the basis of Drug Type, the Global Raynauds Disease Market is segmented into Beta-Blockers, Prolactin inhibitors, Calcineurin inhibitors, Antibiotics / Antineoplastics, Antimigraine agents, Antirheumatics, Antianginal agents, Vasodilators. On the basis of Distribution Channel, the Global Raynauds Disease Market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Store, E-Commerce.
Regional Insights:
Source: Prophecy Market Insights
On region the Global Raynauds Disease Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of the reimbursement scenario and trained practitioners, North America dominates the global market for Raynaud's phenomenon management. Because of the availability of discretionary income and improved health facilities, Europe is expected to emerge in second in the market. The Raynaud's phenomenon management market in Asia Pacific and the Middle East is accelerating due to a growing focus on better health scenarios and facilities.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Drug Type- I Beta-Blockers, Prolactin inhibitors, Calcineurin inhibitors, Antibiotics / Antineoplastics, Antimigraine agents, Antirheumatics, Antianginal agents, Vasodilators By Distribution Channel- Hospital Pharmacies, Retail Pharmacies, Drug Store, E-Commerce |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Raynauds Disease Market report based on Drug Type, Distribution Channel and region.
Global Raynauds Disease Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Raynauds Disease Market Key Players
The key players operating in the systemic sclerosis market are Sanofi-Aventis, Inc., GlaxoSmithKline, TEVA Pharmaceuticals Industries Ltd., Mylan Inc., Sandoz International GmbH, and Unichempharma.
Global Raynauds Disease Market Company Profile
- Sanofi-Aventis, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GlaxoSmithKline
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- TEVA Pharmaceuticals Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mylan Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sandoz International GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Unichempharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Raynauds Disease Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Raynauds Disease Strategies
- Key Questions this Study will Answer
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Raynauds Disease Market, By Drug Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Beta-Blockers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Prolactin Inhibitor
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Calcineurin Inhibitors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antibiotics/Antineoplastics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antimigraine agents
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antirheumatics
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Antianginal Agents
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Vasodilators
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Raynauds Disease Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Retail Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Drug Store
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- E-Commerce
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 203
- Overview
- Global Raynauds Disease Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Sanofi-Aventis, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GlaxoSmithKline
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- TEVA Pharmaceuticals Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Mylan Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sandoz International GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Unichempharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
Global Raynauds Disease Market is segmented based on drug type, distribution channel and region.
Increasing in R&D by researchers is major factor driving the market.
During the forecast period, North America is expected to dominate the market.
The key players operating in the raynauds disease market are Sanofi-Aventis, Inc., GlaxoSmithKline, TEVA Pharmaceuticals Industries Ltd., Mylan Inc., Sandoz International GmbH, and Unichempharma.